Departments of Obstetrics and Gynecology, New York University Langone School of Medicine, New York, New York, Virginia Commonwealth University School of Medicine, Richmond, Virginia, the Medical College of Wisconsin, Milwaukee, Wisconsin, Creighton University School of Medicine, Phoenix, Arizona, the University of California, Davis, Davis, California, the University of Iowa Hospitals and Clinics, Ames, Iowa, and Stony Brook University Hospital, New York, New York; and the American College of Obstetricians and Gynecologists, Washington, DC.
Obstet Gynecol. 2023 Jul 1;142(1):196-210. doi: 10.1097/AOG.0000000000005210. Epub 2023 Jun 7.
Health disparity, defined by the Centers for Disease Control and Prevention (CDC) as "preventable differences in the burden of disease, injury, violence, or opportunities to achieve optimal health that are experienced by socially disadvantaged populations," is seen across multiple diseases. We conducted an evidence review of health disparities and inequities and their mitigation strategies related to ovarian cancer as part of a CDC-sponsored project to develop educational materials for clinicians on the prevention and early diagnosis of gynecologic cancers. Our review found profound disparities in outcomes such as survival, treatment, and stage at diagnosis by factors such as race and ethnicity, insurance, socioeconomic status, and geographic location. We found little direct evidence on mitigation strategies. Studies support equivalent response to equivalent treatment between groups, suggesting that adherence to National Comprehensive Cancer Network guidelines can at least partially mitigate some of the differences.
健康差异是指由疾病控制和预防中心(CDC)定义的“社会弱势群体在疾病、伤害、暴力或实现最佳健康机会方面所承受的可预防的负担差异”,在多种疾病中都存在。我们对卵巢癌相关的健康差异和不公平及其缓解策略进行了证据回顾,这是 CDC 资助的一个项目的一部分,该项目旨在为临床医生开发关于妇科癌症预防和早期诊断的教育材料。我们的审查发现,种族和民族、保险、社会经济地位和地理位置等因素导致生存、治疗和诊断阶段等结果存在明显差异。我们几乎没有关于缓解策略的直接证据。研究支持在不同群体之间对同等治疗的等效反应,这表明遵守国家综合癌症网络指南至少可以部分缓解其中一些差异。
Obstet Gynecol. 2023-7-1
Am J Obstet Gynecol. 2023-10
Curr Opin Obstet Gynecol. 2021-8-1
Obstet Gynecol Surv. 2024-11
J Natl Cancer Inst. 2013-3-28
Expert Rev Pharmacoecon Outcomes Res. 2025-4
Gynecol Oncol Rep. 2025-7-20
Womens Health Rep (New Rochelle). 2025-2-25
Cancer Epidemiol Biomarkers Prev. 2025-6-3
Gynecol Oncol. 2025-1
Obstet Gynecol. 2023-7-1
Obstet Gynecol. 2022-4-1
Obstet Gynecol. 2022-4-1
Am J Clin Oncol. 2021-10-1
Cancer Epidemiol. 2019-6-26
Gynecol Oncol. 2019-3-16